Tirzepatide Well

Medications offered

As listed on the provider’s own site. Whether a product is FDA-approved or compounded is the single most important distinction here — we explain why.

• TirzepatideType not stated
• Zepbound (tirzepatide)FDA-approved
• Mounjaro (tirzepatide)FDA-approved

What they publish

Tirzepatide Well publishes 4 of 12 standard terms. Fields marked “not publicly disclosed” were not stated on the pages we captured, and we have not filled those gaps with assumptions. Compare disclosure across providers

Membership / programme fee

None published separately — the monthly rate is described as covering the programme (as published)

Medication cost

Published at a flat $399 per month, stated not to change regardless of dose level. Brand-name retail comparisons published at approximately $1,519 per month for Zepbound, $1,820 for Wegovy, and $1,300 to $1,900 for Ozempic or Wegovy (as published)

Introductory offer

Not publicly disclosed on the pages we captured.

Insurance

Not publicly disclosed on the pages we captured.

HSA / FSA

Not publicly disclosed on the pages we captured.

Consultation process

A private one-to-one telehealth visit with a doctor who reviews labs, discusses health goals and determines the dose.

Eligibility

Publishes a section on who qualifies for an online tirzepatide prescription. Specific criteria were not published on the pages we captured.

Lab work

States the doctor reviews your labs during the telehealth visit as part of determining the dose.

Pharmacy fulfilment

Not publicly disclosed on the pages we captured.

Shipping

Not publicly disclosed on the pages we captured.

Support services

Not publicly disclosed on the pages we captured.

Cancellation

Not publicly disclosed on the pages we captured.

Refunds

Not publicly disclosed on the pages we captured.

What stands out

• Sells one molecule at one price, which makes it among the easiest offers in this directory to compare.
• States the price is flat at $399 regardless of dose, and says so in direct answer to the question.
• Includes a lab review within the initial telehealth visit rather than prescribing from a questionnaire alone.
• Publishes brand-name retail figures for comparison. Those numbers are at the high end of published retail and considerably above the manufacturer self-pay channels, which run several hundred dollars a month.
• Describes the medication as FDA-approved Zepbound or Mounjaro in places, while the $399 price point is far below any published brand-name channel — the site does not resolve which you would actually receive.
• No refund, cancellation, pharmacy or shipping terms are published.

Questions to ask before you pay

These are things we could not settle from published pages, or that we think are easy to misread. Get answers in writing.

• At $399 a month, is the medication branded Zepbound or Mounjaro, or a compounded tirzepatide? Published brand-name channels cost considerably more.
• Which pharmacy dispenses, and is it a 503A or 503B?
• Are the labs the doctor reviews ones you must obtain and pay for separately?
• What are the refund and cancellation terms — none are published.
• The published brand-name comparisons are retail figures. Have you checked NovoCare and LillyDirect, which are much cheaper?

Frequently asked